Larcher LM[Author] - Search Results

Year	Number of Results
2018	2
2019	2
2020	3
2021	1
2022	2
2023	1
2024	0

1

Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics.

Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, Larcher LM, Chen S, Liu N, Zhao Q, Tran PHL, Chen C, Veedu RN, Wang T. Yang D, et al. Among authors: larcher lm. Theranostics. 2020 Feb 19;10(8):3684-3707. doi: 10.7150/thno.41580. eCollection 2020. Theranostics. 2020. PMID: 32206116 Free PMC article. Review.

2

DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics.

Larcher LM, Pitout IL, Keegan NP, Veedu RN, Fletcher S. Larcher LM, et al. Nucleic Acid Ther. 2023 Jun;33(3):178-192. doi: 10.1089/nat.2022.0066. Epub 2023 Apr 21. Nucleic Acid Ther. 2023. PMID: 37093127 Free PMC article. Review.

3

Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies.

Balachandran AA, Larcher LM, Chen S, Veedu RN. Balachandran AA, et al. Among authors: larcher lm. Cancers (Basel). 2020 Sep 7;12(9):2534. doi: 10.3390/cancers12092534. Cancers (Basel). 2020. PMID: 32906592 Free PMC article. Review.

4

Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development.

Wang T, Chen C, Larcher LM, Barrero RA, Veedu RN. Wang T, et al. Among authors: larcher lm. Biotechnol Adv. 2019 Jan-Feb;37(1):28-50. doi: 10.1016/j.biotechadv.2018.11.001. Epub 2018 Nov 5. Biotechnol Adv. 2019. PMID: 30408510 Free article. Review.

5

Single Stranded Fully Modified-Phosphorothioate Oligonucleotides can Induce Structured Nuclear Inclusions, Alter Nuclear Protein Localization and Disturb the Transcriptome In Vitro.

Flynn LL, Li R, Pitout IL, Aung-Htut MT, Larcher LM, Cooper JAL, Greer KL, Hubbard A, Griffiths L, Bond CS, Wilton SD, Fox AH, Fletcher S. Flynn LL, et al. Among authors: larcher lm. Front Genet. 2022 Apr 6;13:791416. doi: 10.3389/fgene.2022.791416. eCollection 2022. Front Genet. 2022. PMID: 35464859 Free PMC article.

6

Du R, Wang X, Zhou H, Ma L, Larcher LM, Chen C, Wang T. Du R, et al. Among authors: larcher lm. Support Care Cancer. 2022 Dec;30(12):9889-9899. doi: 10.1007/s00520-022-07451-2. Epub 2022 Nov 19. Support Care Cancer. 2022. PMID: 36400979

7

Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides.

Wang T, Larcher LM, Ma L, Veedu RN. Wang T, et al. Among authors: larcher lm. Molecules. 2018 Oct 8;23(10):2564. doi: 10.3390/molecules23102564. Molecules. 2018. PMID: 30297632 Free PMC article.

8

Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells.

Larcher LM, Wang T, Veedu RN. Larcher LM, et al. Molecules. 2019 Jul 7;24(13):2489. doi: 10.3390/molecules24132489. Molecules. 2019. PMID: 31284665 Free PMC article.

9

Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China.

Du R, Wang X, Ma L, Larcher LM, Tang H, Zhou H, Chen C, Wang T. Du R, et al. Among authors: larcher lm. BMC Cancer. 2021 Feb 28;21(1):206. doi: 10.1186/s12885-021-07946-x. BMC Cancer. 2021. PMID: 33639888 Free PMC article.

10

Du R, Wang P, Ma L, Larcher LM, Wang T, Chen C. Du R, et al. Among authors: larcher lm. Health Qual Life Outcomes. 2020 Jun 17;18(1):190. doi: 10.1186/s12955-020-01447-4. Health Qual Life Outcomes. 2020. PMID: 32552846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year